Vor to participate in three upcoming investor conferences

Cambridge, mass., sept. 02, 2021 (globe newswire) -- vor biopharma (nasdaq: vor or the company), a cell and genome engineering company, today announced that the company will be participating in three upcoming virtual investor conferences:
VOR Ratings Summary
VOR Quant Ranking